Access cutting-edge systemic sclerosis treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Access systemic sclerosis specialists in Kansas City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related systemic sclerosis treatment provided free
RESET-SSc: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T cell therapy, in Subjects with Systemic Sclerosis
Sponsor: Cabaletta Bio
Check if you qualify for this systemic sclerosis clinical trial in Kansas City, KS
If you're searching for systemic sclerosis treatment options in Kansas City, KS, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced systemic sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.